• Almeida, G.M., Souza, J.P., Mendes, N.D., Pontelli, M.C., Pinheiro, N.R., Nogueira, G.O., Cardoso, R.S., Paiva, I.M., Ferrari, G.D., Veras, F.P., Cunha, F.Q., Horta-Junior, J.A.C., Alberici, L.C., Cunha, T.M., Podolsky-Gondim, G.G., Neder, L., Arruda, E., Sebollela, A., 2021. Neural Infection by Oropouche Virus in Adult Human Brain Slices Induces an Inflammatory and Toxic Response. Front Neurosci 15, 674576.

  • Bastos Mde, S., Figueiredo, L.T., Naveca, F.G., Monte, R.L., Lessa, N., Pinto de Figueiredo, R.M., Gimaque, J.B., Pivoto Joao, G., Ramasawmy, R., Mourao, M.P., 2012. Identification of Oropouche Orthobunyavirus in the cerebrospinal fluid of three patients in the Amazonas, Brazil. Am J Trop Med Hyg 86, 732-735.

  • Chang, C.H., Peng, W.Y., Lee, W.H., Yang, L., Lin, T.Y., Yang, M.H., Tsai, T.H., 2023. Transporter modulation of molnupiravir and its metabolite beta-D-N4-hydroxycytidine across the blood-brain barrier in a rat. Commun Med (Lond) 3, 150.

  • Connors, K.A., Pedlow, M.R., Frey, Z.D., Cornejo Pontelli, M., Whelan, S.P.J., Duprex, W.P., D'Aiuto, L., Wills, Z.P., Hartman, A.L., 2026. Neural cells are susceptible to historic and recently emerged Oropouche virus strains. PLoS Pathog 22, e1013933.

  • Eigenhuis, K.N., Somsen, H.B., van der Kroeg, M., Smeenk, H., Korporaal, A.L., Kushner, S.A., de Vrij, F.M.S., van den Berg, D.L.C., 2023. A simplified protocol for the generation of cortical brain organoids. Front Cell Neurosci 17, 1114420.

  • Guagliardo, S.A.J., Connelly, C.R., Lyons, S., Martin, S.W., Sutter, R., Hughes, H.R., Brault, A.C., Lambert, A.J., Gould, C.V., Staples, J.E., 2024. Reemergence of Oropouche Virus in the Americas and Risk for Spread in the United States and Its Territories, 2024. Emerg Infect Dis 30, 2241-2249.

  • Jurado, K., Bannerman, C., Philip, D., Miller-Ensminger, T., Kennedy, E., Liu, S., Walsh, K., Ming, G.L., 2025. Oropouche virus disrupts neurodevelopment and is vertically transmitted. Res Sq. [Preprint]. doi:10.21203/rs.3.rs-7512609/v1.

  • Kreit, M., Paul, S., Knoops, L., De Cock, A., Sorgeloos, F., Michiels, T., 2014. Inefficient type I interferon-mediated antiviral protection of primary mouse neurons is associated with the lack of apolipoprotein l9 expression. J Virol 88, 3874-3884.

  • Lang, R., Li, H., Luo, X., Liu, C., Zhang, Y., Guo, S., Xu, J., Bao, C., Dong, W., Yu, Y., 2022. Expression and mechanisms of interferon-stimulated genes in viral infection of the central nervous system (CNS) and neurological diseases. Front Immunol 13, 1008072.

  • Li, J., Wang, X., Ding, Y., Qin, F., de Lima, S.T.S., Papamichail, L., Schraauwen, R., Forato, J., Claro, I.M., Hua, X., Simoes Mello, L.M., Offermans, D.M., Verstegen, M.M.A., Boter, M., Peppelenbosch, M.P., Barbiero, A., Pagani, E., Janssen, H.L.A., Telmos Silva, J.A., Dos Santos, M.N.N., Pincinato, E.C., Proenca-Modena, J.L., Li, P., Anas, A.A., van der Laan, L.J.W., Castilletti, C., Oude Munnink, B.B., de Souza, W.M., Wang, W., Pan, Q., 2026. Human liver-derived organoids recapitulate Oropouche virus infection and manifestation, enabling antiviral drug discovery. Cell Rep Med 7, 102646.

  • Nakamura, K., Fujimoto, K., Hasegawa, C., Aoki, I., Yoshitsugu, H., Ugai, H., Yatsuzuka, N., Tanaka, Y., Furihata, K., Maas, B.M., Wickremasingha, P.K., Duncan, K.E., Iwamoto, M., Stoch, S.A., Uemura, N., 2022. A phase I, randomized, placebo-controlled study of molnupiravir in healthy Japanese to support special approval in Japan to treat COVID-19. Clin Transl Sci 15, 2697-2708.

  • D.M., Pastula, J.D., Beckham, K.L., Tyler, Oropouche Virus: An Emerging Neuroinvasive Arbovirus, Ann. Neurol., 97, 2025, 28, 33.

  • Wang, X., Ding, Y., Duarte-Neto, A.N., Al-Tawfiq, J.A., Wang, W., Pan, Q., Li, J., 2026a. Comprehensive analysis of epidemiological and clinical features of Oropouche virus infection (1975 to 2025): a systematic review. New Microbes New Infect 70, 101725.

  • Wang, X., Li, J., Biharie, A., de Vries, A.C., Bijvelds, M.J.C., Janssen, H.L.A., Wang, W., Souza, W., Pan, Q., 2026b. Oropouche virus infects primary human intestinal organoids and is inhibited by type I and III interferon treatment. mBio 17, e0300325.

  • Winkler, C.W., Woods, T.A., Groveman, B.R., Carmody, A.B., Speranza, E.E., Martens, C.A., Best, S.M., Haigh, C.L., Peterson, K.E., 2019. Neuronal maturation reduces the type I IFN response to orthobunyavirus infection and leads to increased apoptosis of human neurons. J Neuroinflammation 16, 229.